Isoproterenol Hydrochloride (Nexus Pharmaceuticals Inc)


Welcome to the PulseAid listing for the Isoproterenol Hydrochloride drug offered from Nexus Pharmaceuticals Inc. This Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nexus Pharmaceuticals Inc
NON-PROPRIETARY NAME: Isoproterenol Hydrochloride
SUBSTANCE NAME: ISOPROTERENOL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta-Agonists [MoA],beta-Adrenergic Agonist [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2017-08-03
END MARKETING DATE: 0000-00-00


Isoproterenol Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIsoproterenol Hydrochloride from Nexus Pharmaceuticals Inc
LABELER NAME: Nexus Pharmaceuticals Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 0.2(mg/mL)
START MARKETING DATE: 2017-08-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 14789-011_61972ea8-9a94-4748-94ab-358ded59cc9c
PRODUCT NDC: 14789-011
APPLICATION NUMBER: ANDA206961

Other ISOPROTERENOL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthIsuprel
Hospira, Inc.Isuprel
Nexus Pharmaceuticals IncIsoproterenol Hydrochloride
Valeant Pharmaceuticals North America LLCIsuprel